financetom
Business
financetom
/
Business
/
Distilled spirits maker MGP Ingredients beats Q3 sales expectations, hikes FY profit view
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Distilled spirits maker MGP Ingredients beats Q3 sales expectations, hikes FY profit view
Oct 29, 2025 5:00 AM

Overview

* MGP Ingredients ( MGPI ) Q3 sales fell 19% but beat analyst expectations

* Adjusted EPS for Q3 decreased 34% to $0.85

* Company raises full-year adjusted EBITDA and EPS outlook

Outlook

* MGP Ingredients ( MGPI ) raises full-year adjusted EBITDA guidance to $110 mln-$115 mln

* Company tightens full-year sales guidance to $525 mln-$535 mln

* MGP Ingredients ( MGPI ) increases full-year adjusted EPS outlook to $2.60-$2.75

Result Drivers

* BROWN GOODS DECLINE - Sales decrease primarily due to expected declines in brown goods

* PREMIUM PLUS GROWTH - Premium plus brands delivered solid growth, with Penelope Bourbon maintaining strong growth

* INGREDIENT SOLUTIONS SALES INCREASE - Sales rose 9% due to higher wheat protein sales, despite operational challenges

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $130.90 $128 mln

mln (6

Analysts

)

Q3 EPS $0.71

Q3 Net $15.40

Income mln

Q3 $32.29

Adjusted mln

EBITDA

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the distillers & wineries peer group is "buy"

* Wall Street's median 12-month price target for MGP Ingredients Inc ( MGPI ) is $38.00, about 37.7% above its October 28 closing price of $23.67

* The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Disney-owned Star India starts arbitration against Zee over cricket broadcasting deal
Disney-owned Star India starts arbitration against Zee over cricket broadcasting deal
Mar 15, 2024
BENGALURU, March 15 (Reuters) - India's Zee Entertainment Enterprises said on Friday that Walt Disney ( DIS )-owned Star India has started arbitration proceedings against the broadcaster for alleged non-compliance with the terms of a cricket broadcasting agreement between the companies. ...
Microsoft singles out Google's competitive edge in generative AI
Microsoft singles out Google's competitive edge in generative AI
Mar 15, 2024
(In MARCH 14 story corrects to read '15 million euros' (not '15 billion euros'), in paragraph 11) By Foo Yun Chee BRUSSELS, March 14 (Reuters) - Alphabet unit Google enjoys a competitive edge in generative artificial intelligence due to its trove of data and AI-optimised chips, Microsoft ( MSFT ) has told EU antitrust regulators, underscoring the rivalry between the...
Bristol-Myers Squibb Says FDA Grants Accelerated Approval for Lymphoma Treatment
Bristol-Myers Squibb Says FDA Grants Accelerated Approval for Lymphoma Treatment
Mar 15, 2024
03:46 AM EDT, 03/15/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said late Thursday the US Food and Drug Administration granted accelerated approval for its Breyanzi therapy for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The drug maker said the accelerated approval is based on response rate and duration of response,...
ODDITY Tech Prices Secondary Share Offering on Behalf of Selling Stockholder
ODDITY Tech Prices Secondary Share Offering on Behalf of Selling Stockholder
Mar 15, 2024
03:42 AM EDT, 03/15/2024 (MT Newswires) -- ODDITY Tech ( ODD ) said late Thursday it priced a secondary public offering of 4.8 million of its class A shares on behalf of a selling stockholder at $43.50 per share. The selling shareholder has granted underwriters a 30-day option to purchase up to an additional 717,391 shares. The company said it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved